DMCC Speciality Chemicals Ltd

DMCC Speciality Chemicals Ltd has issued a corrigendum to its 105th Annual Report for FY 2025-26. The correction pertains to a typographical error on page 21 in the non-statutory section regarding R&D Investment. The unit of measurement was incorrectly stated as 'Crore' instead of 'Lakh' for an R&D investment amount of ₹182.81. The company clarifies that this error does not impact the financial statements for the year ended March 31, 2026. The corrigendum is to be read in conjunction with the original Annual Report.

DMCC Speciality Chemicals Ltd has submitted its Annual Report for the Financial Year 2025-26 and the Notice for its 105th Annual General Meeting (AGM). The AGM is scheduled for September 11, 2026, at 11:30 a.m. IST, and will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI circulars. The Annual Report, covering the period from April 1, 2025, to March 31, 2026, details the company's business performance, strategic priorities, governance, and financial performance across its commodity chemicals, speciality chemicals, and boron businesses. It is available on the company's website, www.dmcc.com. The report emphasizes the company's strategy of 'Steadiness through the Cycle' by balancing its portfolio and maintaining manufacturing flexibility.

DMCC Speciality Chemicals Ltd has announced its 105th Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 11:30 a.m. IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI circulars. Key agenda items include the adoption of audited standalone and consolidated financial statements for FY 2025-26, declaration of a final dividend of ₹2.50 per equity share, reappointment of Mr. Kuldeep Tiwari as Director, ratification of Cost Auditor's remuneration for FY 2026-27, and approval of commission payment to Non-Executive Directors. The notice of the AGM and the Annual Report for FY 2025-26 have been sent to members and are available on the company's website.

DMCC Speciality Chemicals Ltd reported a significant financial performance for Q1 FY27, with Profit After Taxes (PAT) surging by 166.58% to ₹20.40 crore, compared to ₹7.65 crore in the previous year. Revenue from operations grew by 2.8% to ₹253.01 crore. The company's Managing Director attributed the sharp increase in revenue and profitability primarily to a significant escalation in sulphur and sulfuric acid prices, noting that a substantial portion of the reported profitability reflects inventory gains. These gains are expected to reverse as prices moderate. The company also highlighted operational resilience, with its Dahej and Roha facilities operating without interruption despite global supply chain disruptions. Demand and pricing improved for its Boron segment, and geographical diversification in speciality chemicals is compensating for a subdued European market.

DMCC Speciality Chemicals Ltd has announced the record date for its recommended dividend of 25% (₹2.5 per equity share). The record date is set for Friday, August 21, 2026. The Annual General Meeting (AGM) to approve the dividend is scheduled for Friday, September 11, 2026. E-voting will be available from September 8 to September 10, 2026. The company also provided details for physical shareholders to update their KYC and bank details to ensure timely dividend payment, directing them to its RTA, MUFG Intime India Private Limited.

DMCC Speciality Chemicals Ltd announced that its Board of Directors, in a meeting held on August 10, 2026, considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board meeting commenced at 12:30 p.m. IST and concluded at 2:55 p.m. IST. The statutory auditors have issued their Limited Review Reports on these results. The financial results are available on the company's website, www.dmcc.com. The review was conducted in accordance with applicable standards, and the results were prepared following Indian Accounting Standard 34.

DMCC Speciality Chemicals reported a strong Q1 FY27 (quarter ended June 30, 2026): consolidated revenue nearly doubled to ₹253.01 Cr, up 99.2% YoY from ₹127.04 Cr and 42.4% QoQ from ₹177.64 Cr. Consolidated PAT surged 163.0% YoY to ₹20.40 Cr (from ₹7.76 Cr) and 166.5% QoQ (from ₹7.65 Cr), with EPS at ₹8.18 versus ₹3.11 a year ago and ₹3.07 last quarter. Standalone figures (revenue ₹252.99 Cr, PAT ₹20.41 Cr) are effectively identical to consolidated — the sole subsidiary, DMCC (Europe) GmbH, added just ₹1.64 lakh of revenue this quarter, so the two bases tell the same story. Net profit margin expanded to 8.05% of total income, from 6.09% a year ago and 4.30% last quarter. EBITDA-level operating margin came in at 13.59%, up sharply from 9.96% QoQ but only marginally above the 13.28% posted a year ago. The margin gain is a volume story, not cost relief: raw-material consumption rose to roughly 78% of total income this quarter versus about 61% a year ago, consistent with the raw-material price pressure management flagged on the FY26 Q4 call. Total expenses grew 94.2% YoY to ₹226.08 Cr, just below revenue's 99.2% growth — enough operating leverage to lift margins modestly, but the cost structure is visibly heavier than a year ago. No exceptional items appear in either period, so the growth is entirely operating. On the FY26 Q4 call, management guided that FY27 would be better than FY25-26 for the specialty chemicals segment while flagging near-term volatility, raw-material and working-capital pressure, and early boron-derivative commercial traction; a subsequent earnings-call summary also noted a bearish boron market tied to an energy-driven supply glut expected to weigh on demand into Q1 FY27. Against that cautious framing, a near-doubling of revenue and 163% YoY profit growth reads as a clear beat of the qualitative guidance, even as the flagged raw-material cost pressure shows up in the expense mix. No brokerage consensus or published Q1 FY27 preview for DMCC could be found, so there is no street number to benchmark against, and no separate management press release accompanied this filing. The only other disclosed development this quarter is a minor ₹1.06 Cr ITC demand appeal from May, immaterial to the P&L. Results are unaudited, with the statutory auditor issuing an unmodified limited-review opinion on both statements. Going into Q2 FY27, the open questions are whether raw-material cost intensity eases as management said it expects to manage, and whether the boron/specialty-product ramp shows up in the revenue mix, against management's stated goal of specialty chemicals reaching at least half of total revenue.

DMCC Speciality Chemicals Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item is to consider, approve, and take on record the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. The meeting will also review the Limited Review Reports from the Statutory Auditors. Concurrently, the company has informed that the trading window for its securities will be closed until 48 hours after the board meeting's outcome, reopening on August 13, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

DMCC Speciality Chemicals Limited has responded to a clarification sought by the stock exchange regarding a significant increase in security volume. The company stated that it is in compliance with SEBI (LODR) Regulations, 2015, and has been promptly intimating the exchange of all material events. DMCC Speciality Chemicals confirmed there is no undisclosed price-sensitive information or impending corporate action that could explain the recent volume behavior. The company attributes the movement purely to market-driven factors beyond its control or knowledge.

DMCC Speciality Chemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from July 1st, 2026, and will remain in effect until 48 hours after the conclusion of the Board Meeting where the Unaudited Standalone and Consolidated Financial Results for the quarter ending June 30th, 2026, will be considered. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. All designated employees are advised against trading in the company's securities during this period. The exact date of the Board meeting will be communicated separately.